Q: Over the last few weeks, there have been quite a few articles in various newsletters about device credits. I’m not sure we have the best process in place to identify recalls and under-warranty replacements so I took a look. In the first account I reviewed, I found an item from a St. Jude recall. When I shared my findings with my compliance officer, the response was, “Why are you looking?” Should I not look?
Using revenue reports to create tailored metrics and then monitoring with revenue reconciliation will keep an organization on track to hit revenue goals and ensure that it’s able to plan for the correct amount of revenue.
Q: When an acute rehabilitation hospital transfers a patient at 11:45 p.m. to an acute hospital emergency department, which sends the patient back to acute rehab the next morning, who is responsible for the bill?
Chimeric Antigen Receptor Therapy (CAR-T) is the latest breakthrough in oncology care. Simply put, it involves taking a patient’s cells, sending them to the drug manufacturer where they are re-engineered, and then infusing them back into the patient to attack the patient’s cancer. CAR-T will impact many core aspects of revenue integrity, including reimbursement.
Transitioning to an electronic health system comes with its challenges, from learning new software systems to updating staff roles. Understanding the resources your facility has available is critical to adapting to these changes.
